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MEETING ABSTRACT

Open Access

Introduction of a 6-cyano group in
14-oxygenated N-methylmorphinans influences
in vitro and in vivo pharmacological activities
Valeria Follia1, Mario D Aceto2, Louis S Harris2, Andrew Coop3, Helmut Schmidhammer1, Mariana Spetea1*
From 17th Scientific Symposium of the Austrian Pharmacological Society (APHAR). Joint meeting with the
Hungarian Society of Experimental and Clinical Pharmacology (MFT)
Innsbruck, Austria. 29-30 September 2011
Background
Being a disabling symptom of many medical conditions,
effective pain control is one of the most important therapeutic priorities. Morphine and other opioid drugs produce analgesia primarily through μ opioid (MOP)
receptors, which mediate beneficial but also the nonbeneficial actions. Appropriate identification of novel
opioid analgesics may reduce complications and improve
patient compliance. It was reported that hydrazones,
oximes, carbazones and semicarbazone derivatives of
morphinan-6-ones, e.g. dihydromorphinone or oxymorphone, exhibit high affinity at the MOP receptor [1].
Since most of these structures show high antinociceptive
potency while having less pronounced side effects, it
remains a promising task to convert the carbonyl group
of morphinan-6-ones into various functionalities. In this
study, we aimed to investigate the effect of the replacement of the 6-keto function with a 6-cyano group on
in vitro and in vivo pharmacological profiles.
Methods
Binding affinities at opioid receptors were determined
using competition binding assays in rodent brain membranes. In vitro [ 35 S]GTPgS functional assays were
performed with Chinese hamster ovary (CHO) cell
membranes expressing human opioid receptors. Antinociceptive activities were assessed in mice using tail-flick,
hot-plate and writhing tests.
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Results
Replacement of the 6-keto group by a 6-cyano substituent
in N-methylmorphinan-6-ones leads to qualitative and
quantitative differences in the interaction with opioid
receptors. Consequently, we have conducted a comparison
of the biological activities of the 6-cyanomorphinans to
those of structurally-related opioids, oxycodone, oxymorphone and of the clinically relevant morphine. The 6-cyanomorphinans displayed high affinity and behaved as
agonists at the MOP receptor. When tested in vivo, they
acted as potent antinociceptive agents after subcutaneous
administration, being more active than the 6-keto analogues. The presence of a 14-methoxy or a 14-cinnamyloxy
group instead of a hydroxy group not only increased
in vitro opioid activity at the MOP receptor, but also
enhanced the antinociceptive potency.
Conclusions
Our findings revealed that targeting position 6 in the
morphinan skeleton represents a viable approach for
tuning the pharmacological properties of this class of
opioids. Appropriate molecular manipulations could
afford ligands that, besides their scientific value as pharmacological tools, may also have the potential of emerging as novel analgesics with fewer side effects
compared to currently available treatments.
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